STAT3 and endometrial cancer: In the treatment of lipid metabolism in endometrial cancer, micronized estradiol and progesterone are combined to treat early endometrial cancer (IA/G1 stage), and silibinin can effectively inhibit the proliferation of cancer cells by inhibiting the expression of STAT3 phosphorylation.